If you experience any suspected side effects from your GLP-1 medication, you can report these through the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk, which helps monitor medication safety across the UK
[DOI] [PMC free article] [PubMed] [Google Scholar] 91.Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the Provision of Food Information to Consumers, Amending Regulations (EC) No 1924/2006 and (EC) No 1925/2006 of the European Parliament and of the Council, and Repealing Commission Directive 87/250/EEC, Council Directive 90/496/EEC, Commission Directive 1999/10/EC, Directive 2000/13/EC of the European Parliament and of the Council, Commission Directives 2002/67/EC and 2008/5/EC and Commission Regulation (EC) No 608/2004 Text with EEA Relevance
10.1038/ng.2396 108 PisoschiA
But when we think about risk and benefit, the risk is if youve got low-grade inflammation, youve got early signs of cancer happening, are you going to overload that pathway and promote that cancer to grow bigger, faster? Taylor said
